San Mateo, CA, United States of America

Steven Lacy

USPTO Granted Patents = 5 

 

Average Co-Inventor Count = 4.0

ph-index = 3

Forward Citations = 31(Granted Patents)


Company Filing History:


Years Active: 2018-2024

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Steven Lacy

Introduction

Steven Lacy is a prominent inventor based in San Mateo, CA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of liquid dosage forms for cancer treatment. With a total of 5 patents to his name, Lacy's work is paving the way for advancements in cancer therapies.

Latest Patents

Among his latest patents, Lacy has developed a liquid pharmaceutical composition comprising cabozantinib. This innovative formulation is designed to treat locally advanced or metastatic solid tumors, specifically targeting advanced urothelial cancer and renal cell carcinoma in patients who require effective treatment options. His work in this area demonstrates a commitment to improving patient outcomes through innovative drug delivery methods.

Career Highlights

Lacy's career is marked by his role at Exelixis, Inc., a company dedicated to developing innovative cancer therapies. His expertise in pharmaceutical formulations has been instrumental in advancing the company's mission to provide effective treatment solutions for patients battling cancer. Lacy's contributions have not only enhanced the company's portfolio but have also made a significant impact on the lives of patients.

Collaborations

Lacy has collaborated with notable colleagues, including Dana T Aftab and Gisela Schwab. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas, ultimately leading to the development of groundbreaking therapies.

Conclusion

In summary, Steven Lacy's innovative work in the pharmaceutical industry, particularly in cancer treatment, showcases his dedication to improving patient care. His patents and collaborations reflect a commitment to advancing medical science and providing hope to those affected by cancer.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…